Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 4, 2019 Off

IQVIA’s OCE Technology Platform Selected by Zambon to Establish a Global Multichannel Commercial Engagement Model for OTC Business

By BusinessWire

Italian multinational pharmaceutical company to coordinate all physical and digital activities with pharmacists using IQVIA Technologies’ end-to-end solution. DANBURY, Conn.…

June 4, 2019 Off

Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow

By BusinessWire

The targeted NGS panel enables the detection of 135 RNA and 55 DNA variants associated with non-small cell lung cancer…

June 4, 2019 Off

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

By BusinessWire

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking…

June 4, 2019 Off

Vertex to Present Data at ECFS Conference on Potential Impact of Early Treatment and Long-Term Treatment with CFTR Modulators on the Underlying Cause of CF

By BusinessWire

BOSTON–(BUSINESS WIRE)–#cf—Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data from six scientific abstracts from the company’s portfolio of cystic…

June 4, 2019 Off

Newomics Announces a Co-Marketing Agreement to Improve Performance of High-throughput Workflows

By BusinessWire

BERKELEY, Calif.–(BUSINESS WIRE)–Newomics Inc., a commercial-stage biotechnology company that sells and develops mass spectrometry products, services and diagnostics, today announced…

June 4, 2019 Off

Advaxis to Host Business Update Conference Call on June 11, 2019

By BusinessWire

PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces…

June 4, 2019 Off

Innovation and Unmet Need Drive Prescription Drug Sales to $1.18tr by 2024: New Report from Evaluate Ltd

By BusinessWire

“EvaluatePharma® World Preview 2019, Outlook to 2024” explores growth drivers, growth brakes and top industry performers. LONDON & BOSTON &…

June 4, 2019 Off

Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board

By BusinessWire

New International Team Brings Extensive Ocular Drug Delivery and Scientific Expertise to Advance the Sustained Release of Biologics and Small…

June 4, 2019 Off

Glytec Developing Novel Solution for Selection and Dosing of All Diabetes Medications

By BusinessWire

New product will be the market’s first and only to enable optimization of ALL diabetes medications, insulin and non-insulin alike.…

June 4, 2019 Off

Strand Therapeutics Announces $6 Million Seed Financing to Advance its Programmable mRNA Therapeutics Platform

By BusinessWire

Seed round led by Playground Global to focus on the advancement of next-generation mRNA-based cancer immunotherapies and development of its…

Posts navigation

Previous 1 … 4,735 4,736 4,737 … 5,209 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2023 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off
Proudly powered by WordPress | Theme: Envo Magazine